Pfizer Payout Strains: Income Investors Face Hard Truth
Pfizer paid more in dividends than its free cash flow in 2025, a warning sign for income investors facing hard realit...
Best Dividend ETFs highlights top options for generating income and potential appreciation. This intro guides you through evaluating yields and costs.
13,115 articlesPfizer paid more in dividends than its free cash flow in 2025, a warning sign for income investors facing hard realit...
Investors chase international dividend income, but IDV's 6-7% yield sits beside volatile cycles in oil, banks, and mi...
As of June 26, 2026, the Invesco KBW High Dividend Yield Financial ETF faces renewed scrutiny over whether its double...
A tech-led rally has spotlighted triple-leveraged ETFs, sparking debate on long-run viability. This piece explains ho...
A wave of retirees is piling into ultra-high-yield ETFs, chasing income. Yet by measuring total return after taxes an...
As energy prices swing, investors ask which Vanguard ETF can best capture opportunity while managing risk. This guide...
Choosing the right healthcare ETF in 2026 hinges on costs, diversification, and your risk tolerance. This analysis pi...
A smart AI investment can kickstart long-term growth. This guide uncovers the best artificial intelligence (ai) ETF f...
As traditional bonds struggle to keep pace with inflation, boomers are flocking to high-yield ETFs paying that 10% yi...
Investors aiming to replace a $60,000 salary with monthly dividend ETFs face a simple math problem: how much capital ...
Long-term success in the stock market isn’t about chasing the next hot tip. It’s about a disciplined plan built on lo...
A growing retirement strategy uses MLP ETFs to deliver about $34,000 a year from a $450,000 investment, while avoidin...